8-144414851-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_130849.4(SLC39A4):c.850G>A(p.Glu284Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00513 in 1,613,336 control chromosomes in the GnomAD database, including 320 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_130849.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC39A4 | NM_130849.4 | c.850G>A | p.Glu284Lys | missense_variant | 5/12 | ENST00000301305.8 | NP_570901.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC39A4 | ENST00000301305.8 | c.850G>A | p.Glu284Lys | missense_variant | 5/12 | 1 | NM_130849.4 | ENSP00000301305.4 | ||
SLC39A4 | ENST00000276833.9 | c.775G>A | p.Glu259Lys | missense_variant | 4/11 | 2 | ENSP00000276833.5 | |||
SLC39A4 | ENST00000526658.1 | c.*15G>A | downstream_gene_variant | 3 | ENSP00000434512.1 |
Frequencies
GnomAD3 genomes AF: 0.0274 AC: 4162AN: 152102Hom.: 163 Cov.: 33
GnomAD3 exomes AF: 0.00737 AC: 1850AN: 251038Hom.: 74 AF XY: 0.00559 AC XY: 759AN XY: 135830
GnomAD4 exome AF: 0.00282 AC: 4118AN: 1461116Hom.: 157 Cov.: 33 AF XY: 0.00240 AC XY: 1747AN XY: 726904
GnomAD4 genome AF: 0.0274 AC: 4166AN: 152220Hom.: 163 Cov.: 33 AF XY: 0.0265 AC XY: 1976AN XY: 74446
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jan 24, 2017 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hereditary acrodermatitis enteropathica Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at